nodes	percent_of_prediction	percent_of_DWPC	metapath
Saprisartan—AGTR1—breast cancer	0.926	1	CbGaD
Saprisartan—AGTR1—nipple—breast cancer	0.000711	0.224	CbGeAlD
Saprisartan—AGTR1—epithelium—breast cancer	0.000479	0.151	CbGeAlD
Saprisartan—AGTR1—pituitary gland—breast cancer	0.000389	0.122	CbGeAlD
Saprisartan—AGTR1—adipose tissue—breast cancer	0.000387	0.122	CbGeAlD
Saprisartan—AGTR1—female reproductive system—breast cancer	0.000356	0.112	CbGeAlD
Saprisartan—AGTR1—adrenal gland—breast cancer	0.000347	0.109	CbGeAlD
Saprisartan—AGTR1—endocrine gland—breast cancer	0.000301	0.0947	CbGeAlD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—EDNRB—breast cancer	0.000281	0.00399	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—breast cancer	0.000267	0.0038	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—CXCL8—breast cancer	0.000266	0.00378	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—ITPR1—breast cancer	0.000262	0.00372	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—IL1B—breast cancer	0.000255	0.00363	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—CASP3—breast cancer	0.000255	0.00362	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—IL2—breast cancer	0.000254	0.00362	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—breast cancer	0.000251	0.00357	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL2—breast cancer	0.000251	0.00357	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CCL20—breast cancer	0.000249	0.00355	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR4—breast cancer	0.000249	0.00354	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—GPER1—breast cancer	0.000245	0.00349	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—breast cancer	0.000243	0.00346	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—LPAR1—breast cancer	0.000242	0.00344	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDNRB—breast cancer	0.00024	0.00342	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—STARD8—breast cancer	0.00024	0.00342	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—NMBR—breast cancer	0.000235	0.00335	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR1—breast cancer	0.000234	0.00333	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—breast cancer	0.000232	0.00331	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—GPER1—breast cancer	0.000223	0.00317	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CNR2—breast cancer	0.000222	0.00316	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PTGER1—breast cancer	0.000219	0.00311	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—VEGFA—breast cancer	0.000216	0.00307	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—NMBR—breast cancer	0.000214	0.00304	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—breast cancer	0.000213	0.00304	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—breast cancer	0.000213	0.00304	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—WNT1—breast cancer	0.000209	0.00297	CbGpPWpGaD
Saprisartan—AGTR1—lymph node—breast cancer	0.000208	0.0655	CbGeAlD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—breast cancer	0.000199	0.00283	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PTGER1—breast cancer	0.000199	0.00283	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—TGFB1—breast cancer	0.000198	0.00282	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CCL27—breast cancer	0.000195	0.00277	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CXCL3—breast cancer	0.000195	0.00277	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PDE2A—breast cancer	0.000195	0.00277	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—AGTR2—breast cancer	0.000191	0.00272	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CXCL2—breast cancer	0.000191	0.00272	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—PTHLH—breast cancer	0.000189	0.00269	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—TNF—breast cancer	0.000185	0.00263	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—EDNRB—breast cancer	0.000183	0.0026	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—WNT10B—breast cancer	0.000182	0.00258	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CCL27—breast cancer	0.000177	0.00252	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CXCL3—breast cancer	0.000177	0.00252	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PDE2A—breast cancer	0.000177	0.00252	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CALCA—breast cancer	0.000166	0.00237	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CXCL12—breast cancer	0.000163	0.00231	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CXCR4—breast cancer	0.000163	0.00231	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—RGS2—breast cancer	0.000143	0.00203	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CCL20—breast cancer	0.000141	0.002	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—LGR6—breast cancer	0.000138	0.00196	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CCDC88C—breast cancer	0.000138	0.00196	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—LPAR1—breast cancer	0.000137	0.00194	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—CXCL8—breast cancer	0.000132	0.00188	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—GPER1—breast cancer	0.000132	0.00187	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—SFRP1—breast cancer	0.000132	0.00187	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—RGS2—breast cancer	0.000129	0.00184	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PDE4D—breast cancer	0.000129	0.00183	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CCL20—breast cancer	0.000128	0.00182	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—breast cancer	0.000127	0.00181	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—NMBR—breast cancer	0.000126	0.0018	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CNR2—breast cancer	0.000126	0.00179	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—LPAR1—breast cancer	0.000124	0.00176	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—HEYL—breast cancer	0.000117	0.00167	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PTGER1—breast cancer	0.000117	0.00167	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CUL5—breast cancer	0.000117	0.00167	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PDE4D—breast cancer	0.000117	0.00167	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CNR2—breast cancer	0.000114	0.00162	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—RSPO3—breast cancer	0.00011	0.00157	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CXCL2—breast cancer	0.000108	0.00154	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—AGTR2—breast cancer	0.000108	0.00154	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—WNT10B—breast cancer	0.000107	0.00153	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—WWOX—breast cancer	0.000107	0.00153	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—WNT1—breast cancer	0.000107	0.00153	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PTHLH—breast cancer	0.000107	0.00152	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—INHBB—breast cancer	0.000105	0.00149	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CCL27—breast cancer	0.000105	0.00149	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CXCL3—breast cancer	0.000105	0.00149	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PDE2A—breast cancer	0.000105	0.00149	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—EDNRB—breast cancer	0.000103	0.00147	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—DLL4—breast cancer	9.98e-05	0.00142	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—BMPR2—breast cancer	9.98e-05	0.00142	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CXCL2—breast cancer	9.81e-05	0.0014	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—AGTR2—breast cancer	9.81e-05	0.0014	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PTHLH—breast cancer	9.7e-05	0.00138	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CDH5—breast cancer	9.57e-05	0.00136	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CALCA—breast cancer	9.4e-05	0.00134	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—EDNRB—breast cancer	9.39e-05	0.00134	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—SFRP2—breast cancer	9.38e-05	0.00133	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PRLR—breast cancer	9.21e-05	0.00131	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CXCR4—breast cancer	9.19e-05	0.00131	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CXCL12—breast cancer	9.19e-05	0.00131	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—breast cancer	9.18e-05	0.00131	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—VCP—breast cancer	8.89e-05	0.00126	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—GLI2—breast cancer	8.89e-05	0.00126	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—breast cancer	8.84e-05	0.00126	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—LEPR—breast cancer	8.75e-05	0.00124	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—breast cancer	8.73e-05	0.00124	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CALCA—breast cancer	8.54e-05	0.00121	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—PIK3CA—breast cancer	8.47e-05	0.00121	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CXCR4—breast cancer	8.34e-05	0.00119	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CXCL12—breast cancer	8.34e-05	0.00119	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—breast cancer	8.25e-05	0.00117	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—ARHGDIA—breast cancer	8.13e-05	0.00116	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—FST—breast cancer	7.93e-05	0.00113	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—HEY2—breast cancer	7.83e-05	0.00111	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—RPS6KB2—breast cancer	7.74e-05	0.0011	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—RGS2—breast cancer	7.65e-05	0.00109	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—breast cancer	7.58e-05	0.00108	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CCL20—breast cancer	7.56e-05	0.00108	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—ITPR1—breast cancer	7.45e-05	0.00106	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TLE3—breast cancer	7.32e-05	0.00104	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—LPAR1—breast cancer	7.32e-05	0.00104	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—HEY1—breast cancer	7.25e-05	0.00103	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—DLL1—breast cancer	7.11e-05	0.00101	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—breast cancer	7.01e-05	0.000997	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—HIST1H2BC—breast cancer	6.98e-05	0.000993	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—HIST1H2BK—breast cancer	6.98e-05	0.000993	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—GRB7—breast cancer	6.92e-05	0.000984	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PDE4D—breast cancer	6.92e-05	0.000984	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CSF2—breast cancer	6.88e-05	0.000979	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TAB2—breast cancer	6.8e-05	0.000967	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—ITPR1—breast cancer	6.77e-05	0.000963	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CNR2—breast cancer	6.74e-05	0.000959	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CXCL8—breast cancer	6.74e-05	0.000958	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—MMP3—breast cancer	6.72e-05	0.000956	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—breast cancer	6.71e-05	0.000954	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—DKK1—breast cancer	6.58e-05	0.000936	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—VEGFC—breast cancer	6.53e-05	0.000928	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—JAG2—breast cancer	6.43e-05	0.000915	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—WNT1—breast cancer	6.34e-05	0.000901	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PLA2G4A—breast cancer	6.32e-05	0.000899	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CSF2—breast cancer	6.25e-05	0.000889	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—NOTCH4—breast cancer	6.01e-05	0.000854	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—GZMB—breast cancer	5.97e-05	0.000849	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CXCL2—breast cancer	5.8e-05	0.000824	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—AGTR2—breast cancer	5.8e-05	0.000824	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—BMP2—breast cancer	5.73e-05	0.000815	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PTHLH—breast cancer	5.73e-05	0.000815	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—EDNRB—breast cancer	5.55e-05	0.000789	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PGR—breast cancer	5.49e-05	0.000781	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—THBS1—breast cancer	5.47e-05	0.000778	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—FLT1—breast cancer	5.22e-05	0.000742	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—FGF3—breast cancer	5.2e-05	0.000739	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—SQSTM1—breast cancer	5.2e-05	0.000739	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PIK3CG—breast cancer	5.17e-05	0.000735	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—JAG1—breast cancer	5.13e-05	0.00073	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—NOTCH3—breast cancer	5.11e-05	0.000727	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PARP1—breast cancer	5.11e-05	0.000727	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CALCA—breast cancer	5.05e-05	0.000718	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—RPS6—breast cancer	4.99e-05	0.000709	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—FGF4—breast cancer	4.95e-05	0.000704	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CXCL12—breast cancer	4.93e-05	0.000701	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CXCR4—breast cancer	4.93e-05	0.000701	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PAK1—breast cancer	4.84e-05	0.000688	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TCF7L2—breast cancer	4.75e-05	0.000676	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—AKT2—breast cancer	4.73e-05	0.000673	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PIK3CG—breast cancer	4.69e-05	0.000668	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—HSP90AA1—breast cancer	4.58e-05	0.000652	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—NOTCH2—breast cancer	4.58e-05	0.000652	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PIK3CD—breast cancer	4.54e-05	0.000646	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PRL—breast cancer	4.46e-05	0.000634	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—ADAM10—breast cancer	4.39e-05	0.000625	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—STK11—breast cancer	4.39e-05	0.000625	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PLG—breast cancer	4.34e-05	0.000618	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—AKT2—breast cancer	4.29e-05	0.000611	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—FGF10—breast cancer	4.27e-05	0.000608	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PIK3CD—breast cancer	4.13e-05	0.000587	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PDGFA—breast cancer	4.12e-05	0.000586	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TGFBR2—breast cancer	4.06e-05	0.000578	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—ITPR1—breast cancer	4e-05	0.000569	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MMP3—breast cancer	3.97e-05	0.000565	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—ERBB4—breast cancer	3.97e-05	0.000565	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—STAT5A—breast cancer	3.97e-05	0.000565	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PIK3CB—breast cancer	3.96e-05	0.000563	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—SMAD4—breast cancer	3.85e-05	0.000547	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IGF1R—breast cancer	3.82e-05	0.000544	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CXCL8—breast cancer	3.81e-05	0.000541	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—HES1—breast cancer	3.76e-05	0.000534	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—NCOR1—breast cancer	3.73e-05	0.000531	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PLA2G4A—breast cancer	3.73e-05	0.000531	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CSF2—breast cancer	3.69e-05	0.000525	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—FGF1—breast cancer	3.69e-05	0.000525	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—RAF1—breast cancer	3.68e-05	0.000524	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—NRG1—breast cancer	3.67e-05	0.000521	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—H2AFX—breast cancer	3.64e-05	0.000518	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—IL2—breast cancer	3.64e-05	0.000517	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—E2F1—breast cancer	3.61e-05	0.000514	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PIK3CB—breast cancer	3.6e-05	0.000512	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—SPP1—breast cancer	3.47e-05	0.000494	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CXCL8—breast cancer	3.46e-05	0.000492	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—ERBB3—breast cancer	3.43e-05	0.000488	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—FGFR2—breast cancer	3.43e-05	0.000488	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—IL2—breast cancer	3.3e-05	0.00047	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TERT—breast cancer	3.29e-05	0.000468	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—FGFR1—breast cancer	3.2e-05	0.000455	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—HIF1A—breast cancer	3.15e-05	0.000448	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—LEP—breast cancer	3.07e-05	0.000437	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CAV1—breast cancer	3.04e-05	0.000433	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—KDR—breast cancer	3.01e-05	0.000428	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—ESR1—breast cancer	2.93e-05	0.000417	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—FN1—breast cancer	2.9e-05	0.000412	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—NFKBIA—breast cancer	2.86e-05	0.000407	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—NOTCH1—breast cancer	2.84e-05	0.000403	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PIK3CG—breast cancer	2.77e-05	0.000394	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—KIT—breast cancer	2.77e-05	0.000394	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—APC—breast cancer	2.77e-05	0.000394	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—EGF—breast cancer	2.74e-05	0.00039	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—MAPK3—breast cancer	2.66e-05	0.000378	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—BRAF—breast cancer	2.61e-05	0.000371	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IGF1—breast cancer	2.54e-05	0.000361	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—AKT2—breast cancer	2.54e-05	0.000361	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—EGFR—breast cancer	2.53e-05	0.000359	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PIK3CD—breast cancer	2.44e-05	0.000347	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PIK3CA—breast cancer	2.41e-05	0.000343	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—SERPINE1—breast cancer	2.41e-05	0.000343	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—KRAS—breast cancer	2.39e-05	0.000339	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—NOS3—breast cancer	2.3e-05	0.000327	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PIK3CA—breast cancer	2.19e-05	0.000312	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MDM2—breast cancer	2.18e-05	0.000311	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—RAF1—breast cancer	2.18e-05	0.00031	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—RELA—breast cancer	2.17e-05	0.000308	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—ERBB2—breast cancer	2.15e-05	0.000306	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PIK3CB—breast cancer	2.12e-05	0.000302	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MTOR—breast cancer	2.12e-05	0.000302	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CXCL8—breast cancer	2.04e-05	0.00029	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—HRAS—breast cancer	2.03e-05	0.000289	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CDKN1B—breast cancer	1.99e-05	0.000284	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—AKT1—breast cancer	1.97e-05	0.000281	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CASP3—breast cancer	1.95e-05	0.000278	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IL2—breast cancer	1.95e-05	0.000278	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—IL6—breast cancer	1.94e-05	0.000276	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CCND1—breast cancer	1.9e-05	0.000271	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—JUN—breast cancer	1.9e-05	0.00027	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CTNNB1—breast cancer	1.88e-05	0.000268	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MMP9—breast cancer	1.85e-05	0.000263	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CDKN1A—breast cancer	1.84e-05	0.000262	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PTEN—breast cancer	1.84e-05	0.000261	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MAPK8—breast cancer	1.8e-05	0.000255	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—AKT1—breast cancer	1.79e-05	0.000255	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—SRC—breast cancer	1.7e-05	0.000242	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—VEGFA—breast cancer	1.66e-05	0.000236	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—STAT3—breast cancer	1.64e-05	0.000234	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MAPK3—breast cancer	1.57e-05	0.000223	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MYC—breast cancer	1.53e-05	0.000217	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TGFB1—breast cancer	1.52e-05	0.000217	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—EGFR—breast cancer	1.49e-05	0.000212	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—KRAS—breast cancer	1.41e-05	0.000201	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PIK3CA—breast cancer	1.3e-05	0.000184	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TP53—breast cancer	1.25e-05	0.000178	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—HRAS—breast cancer	1.2e-05	0.00017	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IL6—breast cancer	1.15e-05	0.000163	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—AKT1—breast cancer	1.06e-05	0.000151	CbGpPWpGaD
